4//SEC Filing
DEBEL MARLENE 4
Accession 0001099219-24-000270
CIK 0001099219other
Filed
Dec 16, 7:00 PM ET
Accepted
Dec 17, 4:20 PM ET
Size
12.0 KB
Accession
0001099219-24-000270
Insider Transaction Report
Form 4
METLIFE INCMET
DEBEL MARLENE
EVP & Chief Risk Officer
Transactions
- Exercise/Conversion
Employee Stock Options (right to buy)
2024-12-13−13,107→ 0 totalExercise: $34.33Exp: 2026-02-22→ Common Stock (13,107 underlying) - Sale
Common Stock
2024-12-13$82.88/sh−22,810$1,890,577→ 108,507 total - Exercise/Conversion
Common Stock
2024-12-13$34.33/sh+13,107$449,963→ 121,614 total - Exercise/Conversion
Employee Stock Options (right to buy)
2024-12-13−9,703→ 0 totalExercise: $45.91Exp: 2025-02-23→ Common Stock (9,703 underlying) - Exercise/Conversion
Common Stock
2024-12-13$45.91/sh+9,703$445,465→ 131,317 total
Footnotes (3)
- [F1]The price reported is the weighted average price of the aggregate number of shares sold in multiple open market transactions. The shares were sold at prices between $82.83 to $82.931, inclusive. The reporting person undertakes to provide to the staff of the SEC, MetLife, Inc., or a security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price.
- [F2]The options became exercisable in three substantially equal installments on February 23, 2017, 2018, and 2019.
- [F3]The options became exercisable in three substantially equal installments on February 24, 2016, February 24, 2017, and February 27, 2018.
Documents
Issuer
METLIFE INC
CIK 0001099219
Entity typeother
Related Parties
1- filerCIK 0001770295
Filing Metadata
- Form type
- 4
- Filed
- Dec 16, 7:00 PM ET
- Accepted
- Dec 17, 4:20 PM ET
- Size
- 12.0 KB